Alivus Life Sciences [GLS] vs Marksans Pharma [MARKSANS] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Alivus Life Sciences wins in 7 metrics, Marksans Pharma wins in 4 metrics, with 0 ties. Alivus Life Sciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlivus Life SciencesMarksans PharmaBetter
P/E Ratio (TTM)31.4528.65Marksans Pharma
Price-to-Book Ratio5.234.42Marksans Pharma
Debt-to-Equity Ratio0.6312.93Alivus Life Sciences
PEG Ratio22.31N/AN/A
EV/EBITDA21.3319.93Marksans Pharma
Profit Margin19.21%14.51%Alivus Life Sciences
Operating Margin23.53%14.54%Alivus Life Sciences
EBITDA Margin23.53%14.54%Alivus Life Sciences
Return on Equity17.18%16.73%Alivus Life Sciences
Return on Assets11.43%9.40%Alivus Life Sciences
Free Cash Flow$2.85B$337.45MAlivus Life Sciences
Dividend YieldN/A0.24%N/A
1-Year Return14.54%39.93%Marksans Pharma
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Alivus Life Sciences vs Marksans Pharma Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Alivus Life Sciences vs Marksans Pharma Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...